Hospital News and Research

RSS

Brain research reveals that juggling practice increased gray matter in the motor areas of the brain

Researchers at the Mind Research Network today announced the findings of a scientific study that used brain imaging and Tetris to investigate whether practice makes the brain efficient because it increases gray matter.

1 Sep 2009

Ascent's remanufacturing programs help hospital partners save $82 million

Ascent Healthcare Solutions, a leader in delivering healthcare resource sustainability, today announced that its hospital partners saved an astounding $82 million in unnecessary supply chain costs in the first six months of 2009 with Ascent’s reprocessing and remanufacturing programs.

1 Sep 2009

Medical device report provides key data, information and analysis on diagnostic imaging market

Global Markets Direct’s medical device report: “The Future of the Diagnostic Imaging Market to 2015” report provides key data, information and analysis on the global diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on six market categories including computed tomography systems, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems and x-ray systems.

1 Sep 2009

Warfarin therapy provides substantial protection for elder patients with atrial fibrillation

Warfarin (an oral anticoagulant) therapy for patients with atrial fibrillation - the most common type of significant heart rhythm disorder - appears to be most beneficial for the oldest patients, for those who have had a prior stroke and for patients with multiple risk factors for stroke, according to a new study by Kaiser Permanente and Massachusetts General Hospital researchers.

1 Sep 2009

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the “Company”), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement”) with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.

1 Sep 2009

Cimzia approved for treating adult patients with rheumatoid arthritis

UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

1 Sep 2009

Retail clinics offer better quality care at lower costs than other venues

A new study by Rand Corporation, published in the Annals of Internal Medicine, concludes retail clinics provide quality care at lower costs and equal or better quality than other urgent care options.

1 Sep 2009

Demand for Imprivata's OneSign Platform solution growing

Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it continues to see strong demand for its OneSign Platform solution from the healthcare industry's leading organizations.

1 Sep 2009

CompAnalyst helps healthcare providers gain insight into competitive salary data

Salary.com, Inc., a leading provider of on-demand compensation, payroll and talent management solutions, is providing several healthcare providers with on-demand market pricing software to help them gain insight into competitive salary data.

1 Sep 2009

Caregivers call for comprehensive process to verify signatures

Home care workers called for a hand-examination of each signed card submitted by an organization seeking to decertify the workers' union, saying they had been subjected to lies, coercion, and fraud.

1 Sep 2009

Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the UBS Global Life Sciences Conference in New York at 11:00 a.m. Eastern Time on Monday, September 21, 2009. Mr. Kazimi will provide an update on the Company and its Caldolor product, which Cumberland is preparing to launch following its recent approval by the Food and Drug Administration.

1 Sep 2009

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Seegene today released a new influenza A sub-type screening test, Seeplex FluA ACE Subtyping, that enables simultaneous detection of pandemic novel influenza A (H1N1), seasonal human influenza A H1, seasonal human influenza A H3 and avian influenza A H5 in a single reaction.

1 Sep 2009

Rodents may serve as useful models to interpret parent-offspring relationships

Researchers at the Yerkes National Primate Research Center, Emory University, have demonstrated that prairie voles may be a useful model in understanding the neurochemistry of social behavior. By influencing early social experience in prairie voles, researchers hope to gain greater insight into what aspects of early social experience drive diversity in adult social behavior.

1 Sep 2009

Medsphere secures $12 million to support its development and expansion efforts in the health IT sector

Medsphere Systems Corporation, the leading provider of open source healthcare enterprise solutions, today announced that the company has secured $12 million in financing to support ongoing development and expansion efforts in the health IT sector.

1 Sep 2009

Cardiac resynchronization therapy delays the progression of heart failure

A therapy called cardiac resynchronization can significantly delay the progression of heart failure, according to a major international study published in the New England Journal of Medicine.

1 Sep 2009

New clinical predictors required to determine future asthma attacks

Screening tests used to predict asthma activity in patients may have little tracking success when applied to people with persistent disease who are adhering to their health care regimens, UT Southwestern Medical Center physician report.

1 Sep 2009

Daxor's signed trial agreement with Pacific Cardiology to provide the BVA-100 instrument

Daxor Corporation, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Pacific Cardiology, LLC of Honolulu, Hawaii. This will provide Pacific Cardiology with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume.

1 Sep 2009

Hospital News and Research

Brain research reveals that juggling practice increased gray matter in the motor areas of the brain

Ascent's remanufacturing programs help hospital partners save $82 million

Medical device report provides key data, information and analysis on diagnostic imaging market

Warfarin therapy provides substantial protection for elder patients with atrial fibrillation

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

Cimzia approved for treating adult patients with rheumatoid arthritis

Retail clinics offer better quality care at lower costs than other venues

Demand for Imprivata's OneSign Platform solution growing

CompAnalyst helps healthcare providers gain insight into competitive salary data

Caregivers call for comprehensive process to verify signatures

Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Rodents may serve as useful models to interpret parent-offspring relationships

Medsphere secures $12 million to support its development and expansion efforts in the health IT sector

Cardiac resynchronization therapy delays the progression of heart failure

New clinical predictors required to determine future asthma attacks

Daxor's signed trial agreement with Pacific Cardiology to provide the BVA-100 instrument

Study provides insights into genes that help maintain youthfulness of the skin

BioSyent's subsidiary BioSyent Pharma signs an exclusive product development agreement

Psychological therapy for breast cancer patients reduces blood inflammation levels

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News